Abstract
Purpose
We aimed to assess risk factors of candida-related Vascular Graft Infections (VGIs).
Methods
We did a case–control study (1:4) matched by age and year of infection, nested in a cohort of patient with a history of VGIs. Cases were defined by a positive culture for Candida spp. in biological samples and controls were defined by a positive culture for bacterial strains only in biological samples. Risk factors for Candida-related VGIs were investigated using multivariate logistic regression. Mortality were compared using survival analysis.
Results
16 Candida-related VGIs were matched to 64 bacterial-related VGIs. The two groups were comparable regarding medical history and clinical presentation. Candida-related VGIs were associated with bacterial strains in 88% (14/16). Gas/fluid-containing collection on abdominal CT scan and the presence of an aortic endoprosthesis were risk factors for Candida spp.-related VGIs [RRa 10.43 [1.81–60.21] p = 0.009 RRa and 6.46 [1.17–35.73] p = 0.03, respectively]. Candida-related VGIs were associated with a higher mortality when compared to bacterial-related VGIs (p = 0.002).
Conclusions
Candida-related VGIs are severe. Early markers of Candida spp. infection are needed to improve their outcome. The suspicion of aortic endoprosthesis infection may necessitate probabilistic treatment with antifungal agents.
Similar content being viewed by others
Data availability
The data is available from the authors (OR) upon reasonable request.
References
Darouiche RO. Treatment of Infections Associated with Surgical Implants. N Engl J Med. 2004;350:1422–9. https://doi.org/10.1056/NEJMra035415.
Oderich GS, Bower TC, Cherry KJ, Panneton JM, Sullivan TM, Noel AA, et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg. 2006;43:1166–74. https://doi.org/10.1016/j.jvs.2006.02.040.
Davila VJ, Stone W, Duncan AA, Wood E, Jordan WD, Zea N, et al. A multicenter experience with the surgical treatment of infected abdominal aortic endografts. J Vasc Surg. 2015;62:877–83. https://doi.org/10.1016/j.jvs.2015.04.440.
Rawson TM, Lee MJ, Khanna P, Gopal Rao G, Renton S, Buckley J. Microbiological characterisation of prosthetic vascular graft infection. J Infect. 2015;71:400–2. https://doi.org/10.1016/j.jinf.2015.04.008.
Fariñas MC, Campo A, Duran R, Sarralde JA, Nistal JF, Gutiérrez-Díez JF, et al. Risk factors and outcomes for nosocomial infection after prosthetic vascular grafts. J Vasc Surg. 2017;66:1417–26. https://doi.org/10.1016/j.jvs.2017.06.078.
Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23:219. https://doi.org/10.1186/s13054-019-2497-3.
Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25–31. https://doi.org/10.1086/504810.
Legout L, Sarraz-Bournet B, D’Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 2012;18:352–8. https://doi.org/10.1111/j.1469-0691.2011.03618.x.
Szczot M, Meybeck A, Legout L, Pasquet A, Van Grunderbeeck N, Langlois J, et al. Vascular graft infections in the intensive care unit: Clinical spectrum and prognostic factors. J Infect. 2011;62:204–11. https://doi.org/10.1016/j.jinf.2010.12.006.
Revest M, Camou F, Senneville E, Caillon J, Laurent F, Calvet B, et al. Medical treatment of prosthetic vascular graft infections: Review of the literature and proposals of a Working Group. Int J Antimicrob Agents. 2015;46:254–65. https://doi.org/10.1016/j.ijantimicag.2015.04.014.
Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2011;54:58–63. https://doi.org/10.1016/j.jvs.2010.11.111.
Schoell T, Manceau G, Chiche L, Gaudric J, Gibert H, Tresallet C, et al. Surgery for secondary aorto-enteric fistula or erosion (SAEFE) complicating aortic graft replacement: a retrospective analysis of 32 patients with particular focus on digestive management. World J Surg. 2015;39:283–91. https://doi.org/10.1007/s00268-014-2750-5.
Smeds MR, Duncan AA, Harlander-Locke MP, Lawrence PF, Lyden S, Fatima J, et al. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016;63:332–40. https://doi.org/10.1016/j.jvs.2015.08.113.
Cernohorsky P, Reijnen MMPJ, Tielliu IFJ, van Sterkenburg SMM, van den Dungen JJAM, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54:327–33. https://doi.org/10.1016/j.jvs.2010.12.067.
Makar R, Reid J, Pherwani AD, Johnston LC, Hannon RJ, Lee B, et al. Aorto-enteric fistula following endovascular repair of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2000;20:588–90. https://doi.org/10.1053/ejvs.2000.1247.
Kadhim MMK, Rasmussen JBG, Eiberg JP. Aorto-enteric fistula 15 years after uncomplicated endovascular aortic repair with unforeseen onset of endocarditis. EJVES Short Reports. 2016;31:16–8. https://doi.org/10.1016/j.ejvssr.2016.03.004.
Puges M, Bérard X, Caradu C, Accoceberry I, Gabriel F, Cazanave C. Fungal vascular graft and endograft infections are frequently associated with aorto-enteric fistulas. Eur J Vasc Endovasc Surg. 2021;62:819–20. https://doi.org/10.1016/j.ejvs.2021.07.002.
Kilic A, Arnaoutakis DJ, Reifsnyder T, Black JH, Abularrage CJ, Perler BA, et al. Management of infected vascular grafts. Vasc Med. 2016;21:53–60. https://doi.org/10.1177/1358863X15612574.
Low RN, Wall SD, Jeffrey RB, Sollitto RA, Reilly LM, Tierney LM. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990;175:157–62. https://doi.org/10.1148/radiology.175.1.2315475.
Ostrosky-Zeichner L, Al-Obaidi M. Invasive fungal infections in the intensive care unit. Infect Dis Clin North Am. 2017;31:475–87. https://doi.org/10.1016/j.idc.2017.05.005.
Lefort A, Chartier L, Sendid B, Wolff M, Mainardi J-L, Podglajen I, et al. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18:E99-109. https://doi.org/10.1111/j.1469-0691.2012.03764.x.
Baddley JW, Benjamin DK, Patel M, Miró J, Athan E, Barsic B, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519–29. https://doi.org/10.1007/s10096-008-0466-x.
Omran S, Gröger S, Shafei B, Schawe L, Bruder L, Haidar H, et al. Outcomes of Candida and non-candida aortic graft infection. Vasc Endovascular Surg. 2023;57:97–105. https://doi.org/10.1177/15385744221129236.
Acknowledgments
The authors thank Hospital of Tourcoing’s data manager for their valuable contribution.
Funding
No funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
T.C., O.R., E.S. wrote the protocole T.C., J.S., O.L.,P.D., O.R., N.B., P.P. and E.S. collected the data O.R. did the statistical analysis. T.C., O.R., E.S. wrote the main manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
OR reports personal fees and non-financial support from ViiV healthcare, Gilead, MSD, not related to this work.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Caulier, T., Senneville, E., Sobocinski, J. et al. Burden of Candida-related vascular graft infection: a nested-case control study. Infection (2024). https://doi.org/10.1007/s15010-023-02172-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-023-02172-y